Autopsy report · NCT04667182

A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes

“Study was withdrawn prior to enrolment due to business decision.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Eli Lilly and Company

Sponsor type

Industry

Conditions

Type 1 Diabetes; Type 2 Diabetes

Interventions

Meal-Tagging App and Web-based Portal:; Fitness Tracker

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
  “Study is withdrawn due to company decision.” (85% match in meaning)
• Sym004 Versus TAS-102 in Patients With mCRC
  “Study was withdrawn due to administrative reasons” (82% match in meaning)
• A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
  “Study is being withdrawn for business reasons” (82% match in meaning)
• A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
  “Study was withdrawn due to scientific and business considerations.” (80% match in meaning)
• Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
  “This study was withdrawn for business reasons.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.